Metformin, a metabolic drug approved to treat individuals with type 2 diabetes, may also be useful to treat lupus, according to a new study from University of Florida, published in Science Translational Medicine. The study, “Normalization of CD4+ T Cell Metabolism…
A private supporter of novel lupus research, the Lupus Research Institute (LRI) is celebrating its 15th anniversary with the announcement of a series of grants awarded in recognition of new talent, diversity and excellency. Twelve Novel Research Grants were awarded within the categories of “Strategies for Better, Safer Treatments,” “Innovative Technologies…
In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) network released the SLICC-12, which is a method that can be used to classify systemic lupus erythematosus (SLE). A recent report published in Arthritis Research and Therapy by a group at Linköping University in Sweden described the…
A study published in the journal Pediatric Rheumatology highlighted the importance of recognizing skin lesions in children with juvenile-onset systemic lupus erythematosus. The study is entitled “Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature.” Systemic lupus erythematosus (SLE) is a severe autoimmune disease…
Researchers at the Karolinska University Hospital in Stockholm, Sweden, recently discovered that two specific small proteins are associated with a poor outcome in lupus nephritis patients. The study was published in the journal BMC Immunology and is entitled “IL-17 and…
The American Autoimmune Related Diseases Association (AARDA) recently released a white paper to inform and educate AARDA members and the patient community in general about biosimilar medicines (drugs similar but not identical to original biologic medicines) and their potential safety concerns. AARDA is a national nonprofit health…
The Strategic Pharma-Academic Research Consortium for Translational Medicine (SPARC) is going to provide more than $1.9 million to support studies on autoimmune diseases. The grant will be given to medical research universities located in the Midwest. The Indiana Clinical and Translational Sciences Institute leads SPARC, and the investigations will focuse…
Researchers at the Center for Clinical and Translational Science, Ohio State University developed the first chimeric mouse model to study Sjögren’s syndrome, an autoimmune disorder. Notably, this new mouse model will also allow researchers to study the human characteristics of other autoimmune diseases,…
A clinical trial study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), and led by Dr. David Wofsy at University of California, San Francisco and Dr. Betty Diamond at Feinstein Institute for Medical Research, New York, assessed the efficacy…
Anthera Pharmaceuticals, Inc. announced the completion of its Phase 3 trial (CHABLIS-SC1), which evaluated the effect of blisibimod in patients suffering with systemic lupus erythematosus. The CHABLIS-SC1 study was evaluated by an independent statistician to assess the SRI-6 response 24 weeks after the beginning of the…